Logo image of BMR

BEAMR IMAGING LTD (BMR) Stock Fundamental Analysis

USA - NASDAQ:BMR - IL0011832438 - Common Stock

2.78 USD
-0.13 (-4.47%)
Last: 10/10/2025, 9:12:49 PM
2.86 USD
+0.08 (+2.88%)
After Hours: 10/10/2025, 9:12:49 PM
Fundamental Rating

3

Taking everything into account, BMR scores 3 out of 10 in our fundamental rating. BMR was compared to 282 industry peers in the Software industry. While BMR has a great health rating, there are worries on its profitability. BMR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BMR has reported negative net income.
In the past year BMR has reported a negative cash flow from operations.
In the past 5 years BMR always reported negative net income.
In the past 5 years BMR reported 4 times negative operating cash flow.
BMR Yearly Net Income VS EBIT VS OCF VS FCFBMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -1M -2M -3M

1.2 Ratios

With a Return On Assets value of -33.81%, BMR is not doing good in the industry: 76.95% of the companies in the same industry are doing better.
BMR has a Return On Equity of -35.84%. This is in the lower half of the industry: BMR underperforms 63.83% of its industry peers.
Industry RankSector Rank
ROA -33.81%
ROE -35.84%
ROIC N/A
ROA(3y)-13.88%
ROA(5y)-18.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BMR Yearly ROA, ROE, ROICBMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 100 -100 200 -200

1.3 Margins

Looking at the Gross Margin, with a value of 90.54%, BMR belongs to the top of the industry, outperforming 98.23% of the companies in the same industry.
In the last couple of years the Gross Margin of BMR has declined.
The Profit Margin and Operating Margin are not available for BMR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5YN/A
BMR Yearly Profit, Operating, Gross MarginsBMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

BMR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BMR has more shares outstanding
Compared to 1 year ago, BMR has an improved debt to assets ratio.
BMR Yearly Shares OutstandingBMR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
BMR Yearly Total Debt VS Total AssetsBMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

BMR has an Altman-Z score of 20.70. This indicates that BMR is financially healthy and has little risk of bankruptcy at the moment.
BMR has a better Altman-Z score (20.70) than 94.33% of its industry peers.
BMR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 20.7
ROIC/WACCN/A
WACC9.1%
BMR Yearly LT Debt VS Equity VS FCFBMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

A Current Ratio of 13.85 indicates that BMR has no problem at all paying its short term obligations.
BMR has a better Current ratio (13.85) than 96.10% of its industry peers.
A Quick Ratio of 13.85 indicates that BMR has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 13.85, BMR belongs to the best of the industry, outperforming 96.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.85
Quick Ratio 13.85
BMR Yearly Current Assets VS Current LiabilitesBMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

0

3. Growth

3.1 Past

BMR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.95%.
Looking at the last year, BMR shows a small growth in Revenue. The Revenue has grown by 5.68% in the last year.
BMR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.44% yearly.
EPS 1Y (TTM)-118.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.75%
Revenue 1Y (TTM)5.68%
Revenue growth 3Y-2.44%
Revenue growth 5YN/A
Sales Q2Q%6.69%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BMR Yearly Revenue VS EstimatesBMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 1M 2M 3M
BMR Yearly EPS VS EstimatesBMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -0.05 -0.1 -0.15 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BMR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BMR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BMR Price Earnings VS Forward Price EarningsBMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BMR Per share dataBMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BMR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEAMR IMAGING LTD

NASDAQ:BMR (10/10/2025, 9:12:49 PM)

After market: 2.86 +0.08 (+2.88%)

2.78

-0.13 (-4.47%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-05 2025-08-05
Earnings (Next)03-04 2026-03-04
Inst Owners1.82%
Inst Owner Change0%
Ins Owners23.46%
Ins Owner Change0%
Market Cap43.17M
Analysts80
Price Target8.16 (193.53%)
Short Float %8.52%
Short Ratio1.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.45
P/FCF N/A
P/OCF N/A
P/B 2.37
P/tB 3.2
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.27
BVpS1.17
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.81%
ROE -35.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.54%
FCFM N/A
ROA(3y)-13.88%
ROA(5y)-18.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.78%
GM growth 5YN/A
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 11.02%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.85
Quick Ratio 13.85
Altman-Z 20.7
F-Score3
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)314.52%
Cap/Depr(5y)189.33%
Cap/Sales(3y)5.82%
Cap/Sales(5y)3.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-54.75%
EPS Next Y-266.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.68%
Revenue growth 3Y-2.44%
Revenue growth 5YN/A
Sales Q2Q%6.69%
Revenue Next Year5.06%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-173.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.15%
OCF growth 3YN/A
OCF growth 5YN/A